Disorders of the blood in changing environmental conditions.
D000380:Agranulocytosis / Q000139:chemically induced / Q000276:immunology; D000632:Aminopyrine / Q000009:adverse effects; D000741:Anemia, Aplastic / Q000139:chemically induced; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000917:Antibody Formation; D000927:Anticonvulsants / Q000009:adverse effects; D000941:Antigens; D013956:Antithyroid Agents / Q000009:adverse effects; D004777:Environment; D004781:Environmental Exposure; D006046:Gold / Q000009:adverse effects; D006402:Hematologic Diseases / Q000209:etiology*; D006801:Humans; D007306:Insecticides / Q000009:adverse effects; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism; D007962:Leukocytes / Q000276:immunology; D007970:Leukopenia / Q000139:chemically induced; D009747:Nutritional Physiological Phenomena; D010653:Phenylbutazone / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D012997:Solvents / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000941:Antigens; D013956:Antithyroid Agents; D007306:Insecticides; D012997:Solvents; D013449:Sulfonamides; D014149:Tranquilizing Agents; D000632:Aminopyrine; D006046:Gold; D011803:Quinine; D007501:Iron; D010653:Phenylbutazone